MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by ACTG

News headline image
ACTG Announces Behavioral Health and Implementation Study to Optimize Long-Acting HIV Treatment among People who have Struggled to Maintain HIV Suppression
From ACTG
Via GlobeNewswire
News headline image
ACTG Launches HIV Cure Study Evaluating Novel Approach Targeting the HIV Reservoir
From ACTG
Via GlobeNewswire
News headline image
ACTG Launches Landmark Study Evaluating Treatments for Depressive Disorders with or without Mild Neurocognitive Disorder among People Living with HIV
From ACTG
Via GlobeNewswire
News headline image
ACTG Launches Critical Study Evaluating Hormone Therapy for Women Living with HIV in the Menopause Transition
From ACTG
Via GlobeNewswire
News headline image
ACTG Announces Publication of STOMP Results in the New England Journal of Medicine
From ACTG
Via GlobeNewswire
News headline image
ACTG Announces Publication of LATITUDE Findings in the New England Journal of Medicine
From ACTG
Via GlobeNewswire
News headline image
ACTG Launches IPACE-HIV to Study Frailty Intervention
From ACTG
Via GlobeNewswire
News headline image
ACTG Presents SLIM LIVER Findings at AASLD Liver Meeting Demonstrating Improvements in Biomarkers of Cardiovascular Risk among People Living with HIV and MASLD Who Receive Semaglutide
From ACTG
Via GlobeNewswire
News headline image
ACTG Presents Important Findings from REPRIEVE at CROI 2025
From ACTG
Via GlobeNewswire
News headline image
ACTG Presents Study at CROI Demonstrating Potential of CMV-specific Antiviral Inhibitor to Improve Aging-Related Outcomes among People Living with HIV and CMV (Cytomegalovirus)
From ACTG
Via GlobeNewswire
News headline image
ACTG Presents Data from Mpox Study STOMP at CROI
From ACTG
Via GlobeNewswire
News headline image
ACTG Presents Four Studies at CROI Describing Findings from SLIM LIVER
From ACTG
Via GlobeNewswire
News headline image
ACTG Presents Study at CROI Demonstrating Increased Risk of Obesity and Cardiometabolic Disease After Switch to Integrase Inhibitor-Containing Regimen
From ACTG
Via GlobeNewswire
News headline image
ACTG Launches Second HIV Cure Clinical Trial in Africa
From ACTG
Via GlobeNewswire
News headline image
ACTG Announces Publication of BEe-HIVe Trial in JAMA
From ACTG
Via GlobeNewswire
News headline image
ACTG Presents Two Studies Providing Insights Into TB Treatment at Union Conference on Lung Health
From ACTG
Via GlobeNewswire
News headline image
ACTG Presents Data Analysis at AIDS 2024 Showing Association between Elevated Risk of Cardiovascular Events and Abacavir Use Among People Living with HIV
From ACTG
Via GlobeNewswire
News headline image
ACTG Announces Launch of its First HIV Cure Clinical Trial in Africa
From ACTG
Via GlobeNewswire
News headline image
ACTG SLIM LIVER Findings Published in Annals of Internal Medicine
From ACTG
Via GlobeNewswire
News headline image
ACTG Announces Launch of Clinical Trial Evaluating Combination of Three Novel Immune-based Therapies for HIV Cure
From ACTG
Via GlobeNewswire
News headline image
ACTG CROI Presentation Demonstrates Superiority of HepB-CpG Vaccine Over Conventional Hepatitis B Vaccine Among People Living With HIV Who Have Not Previously Responded to Vaccination
From ACTG
Via GlobeNewswire
News headline image
ACTG Presents Study at CROI Demonstrating Efficacy of Long-Acting Injectable Treatment Among People Who Had Previously Been Unable to Maintain Viral Suppression on Daily Oral Medication
From ACTG
Via GlobeNewswire
News headline image
ACTG CROI Presentations Show That Semaglutide Improves Metabolic-Associated Steatotic Liver Disease Among People Living With HIV
From ACTG
Via GlobeNewswire
News headline image
ACTG Presents Study at CROI Elucidating Mechanism of CMV on Aging-Related Pathways in HIV
From ACTG
Via GlobeNewswire
News headline image
ACTG Announces Launch of Clinical Trial Evaluating Drug-Drug Interaction in Shortened Tuberculosis Regimen Among People Living with HIV
From ACTG
Via GlobeNewswire
News headline image
ACTG Announces Launch of Clinical Trial Evaluating Novel Treatment for Tuberculous Meningitis
From ACTG
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story